A Study on Financial performance of select pharmaceutical companies in India

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

SYEDA RABAB MEHDI ABEDI

A Study on Financial performance of select pharmaceutical companies in India

Authors: SYEDA RABAB MEHDI ABEDI

Unique Paper ID: 167968
Volume: 11
Issue: 4
PageNo: 895-899

Keywords: Duepoint Analysis Pharmacetical Companies Financial Ratios

Abstract:
Being the world’s third-largest industry by volume and thirteenth largest in terms of value, Indian Pharmaceutical industry is likely to become leader in manufacturing soon. In past 30 years Indian pharmaceutical industry has emerged as one of the major leader in drug production from almost nothing. Earlier multinational companies used to import drugs either in fully formulated or bulk form. The credit for this steep curve in development can be given to the twin benefit, firstly the increase in domestic consumption capacity of India and secondly to the various export opportunities available in India. It is one of the major contributors to Indian economy with a growth percentage of 7-8%. Indian pharmaceutical industry is expected to outperform the global pharmaceutical industry expected to grow at 5% per annum as it is assumed to grow at 15 per cent per annum.. In this paper we are going to discuss about Du point analysis on 12 leading companies in the pharmaceutical industry in India. Starting with Sun pharma, one of the leading company in India having highest assets, we extend our discussion to, Aurobindo Pharma Ltd., Cipla Ltd., Lupin Laboratories Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 4
PageNo: 895-899

A Study on Financial performance of select pharmaceutical companies in India

Available:https://ijirt.org/article?manuscript=167968

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now